ROCKY HILL, Conn., June 14, 2018 /PRNewswire-PRWeb/ -- Connecticut Innovations (CI), Connecticut's
"We're honored to have Tom Scott participate in the keynote fireside chat at the VentureClash competition," said Matt McCooe, CEO of Connecticut Innovations. "Tom is an established entrepreneur with a tremendous track record of success. I am confident that our early-stage company finalists will benefit tremendously from his wisdom and guidance."
Tom Scott's entrepreneurial journey has been as diverse as it has been successful. He is currently the CEO of The Nantucket Project, an annual conference bringing together leading thinkers and decision-makers in an environment designed to spark ideas and conversation that leads to meaningful change.
He began his career by co-founding beverage company Nantucket Nectars, which hit the "Inc. 500" list of fastest-growing U.S. companies five years in a row. After selling to Cadbury Schweppes, Tom turned to filmmaking, directing and producing. His films and television shows have garnered a Film Independent Spirit Award, 16 Emmys, and honors at the Cannes and Sundance film festivals. A resident of Connecticut, Tom is also the chairman of the Nantucket Film Festival.
The VentureClash finals event will feature final presentations from 10 of the world's most promising early-stage companies, with founders pitching their businesses in front of experts, investors, customers and academics engaged in their industries.
For more information on qualifications, requirements, guidelines and application, visit http://www.ventureclash.com.
About VentureClash Managed by Connecticut Innovations, VentureClash is Connecticut's global venture challenge focused on early-stage companies. The challenge, launched in 2016, identifies the most promising companies in digital health, fintech, insurtech and the Internet of Things that will compete for investments from a $5 million award pool. For more information, visit http://www.ventureclash.com.
About Connecticut Innovations Connecticut Innovations (CI) is Connecticut's strategic venture capital arm and is the leading source of financing and ongoing support for innovative, growing companies. CI provides venture capital and strategic guidance for early-stage technology companies, and connections to its well-established network of partners and professionals. For more information, please visit http://www.ctinnovations.com.
Subscribe to our Free Newsletters!
Mastocytosis is a rare condition marked by accumulation of mast cells under the skin and various ...
Lusutrombopag is used to treat abnormally low platelet counts (thrombocytopenia) in adult patients ...
Stereotypic movement disorder (SMD) is a motor disorder, associated with neurodevelopmental ...View All